Thursday, July 14th, 2016 adds“CytomX Therapeutics Inc Pipeline Review – Analysis Of Key Players And Enlists All Their Major And Minor Projects 2016”reports to its database.This Report Include Key Players Information Involved In Therapeutics Development.


The ‘CytomX Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the CytomX Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by CytomX Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

For more information or any query mail at [email protected]

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


- The report provides a snapshot of the pipeline therapeutic landscape of CytomX Therapeutics, Inc. 
- The report provides overview of CytomX Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses CytomX Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features CytomX Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects


Reasons to buy

- Evaluate CytomX Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline 
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for CytomX Therapeutics, Inc. 
- Identify potential new clients or partners in the target demographic 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding CytomX Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents 2 
List of Tables 5 
List of Figures 5 
CytomX Therapeutics, Inc. Snapshot 6 
CytomX Therapeutics, Inc. Overview 6 
Key Information 6 
Key Facts 6 

CytomX Therapeutics, Inc. - Research and Development Overview 7 
Key Therapeutic Areas 7 
CytomX Therapeutics, Inc. - Pipeline Review 10 
Pipeline Products by Stage of Development 10 
Pipeline Products - Monotherapy 11 
CytomX Therapeutics, Inc. - Pipeline Products Glance 12 
CytomX Therapeutics, Inc. - Early Stage Pipeline Products 12 
Preclinical Products/Combination Treatment Modalities 12 
Discovery Products/Combination Treatment Modalities 13 

CytomX Therapeutics, Inc. - Drug Profiles 14 
CTX-023 14 
Product Description 14 
Mechanism of Action 14 
R&D Progress 14 
CTX-033 15 
Product Description 15 
Mechanism of Action 15 
R&D Progress 15 
CTX-1003 16 
Product Description 16 
Mechanism of Action 16 
R&D Progress 16 
CX-072 17 
Product Description 17 
Mechanism of Action 17 
R&D Progress 17 
CX-2009 18 
Product Description 18 
Mechanism of Action 18 
R&D Progress 18 
Monoclonal Antibody Conjugate to Target CD-71 for Oncology 19 
Product Description 19 
Mechanism of Action 19 
R&D Progress 19 
Monoclonal Antibody Conjugate to Target ITGA-3 for Oncology 20 
Product Description 20 
Mechanism of Action 20 
R&D Progress 20 
Monoclonal Antibody Conjugated to Target CD3 and EGFR for Solid Tumor 21 
Product Description 21 
Mechanism of Action 21 
R&D Progress 21 
Monoclonal Antibody Conjugates 1 for Oncology 22 
Product Description 22 


For more information or any query mail at [email protected]


Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


CytomX Therapeutics Inc,CytomX Therapeutics Inc Market,CytomX Therapeutics Inc Industry,CytomX Therapeutics Inc Industry Trends,CytomX Therapeutics Inc Market Share,CytomX Therapeutics Inc Market Growth,CytomX Therapeutics Inc Market Size,CytomX Therapeut




More Formats

View QR Code